CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue:
Total revenue	$ 665,028	$ 498,931	$ 2,058,543	$ 1,117,114
Operating expenses:
Third-party medical costs (Related parties comprised $0 and $249,819 in the nine months ended September 30, 2022 and 2021, respectively)	489,565	381,316	1,566,661	868,177
Direct patient expense (Related parties comprised $1,972 and $6, in the three months ended September 30, 2022 and 2021, respectively, and $6,490 and $1,502, in the nine months ended September 30, 2022 and 2021, respectively)	63,867	50,368	177,190	120,212
Selling, general, and administrative expenses (Related parties comprised $2,709 and $4,225, in the three months ended September 30, 2022 and 2021, respectively, and $6,913 and $9,814, in the nine months ended September 30, 2022 and 2021, respectively)	111,765	76,618	314,617	158,786
Depreciation and amortization expense	25,343	16,955	64,215	30,746
Transaction costs and other (Related parties comprised $0 and $1,483 in the nine months ended September 30, 2022 and 2021, respectively)	5,033	11,206	19,616	36,274
Change in fair value of contingent consideration	900	(3,940)	(9,525)	(4,152)
Total operating income (expenses)	696,473	532,523	2,132,774	1,210,043
Income (loss) from operations	(31,445)	(33,592)	(74,231)	(92,929)
Other income and expense:
Interest expense	(16,451)	(16,023)	(42,868)	(36,363)
Interest income	4	1	7	4
Loss on extinguishment of debt	0	0	(1,428)	(13,225)
Change in fair value of warrant liabilities	(65,721)	(14,650)	(8,383)	24,565
Other income (loss)	354	(29)	884	(54)
Total other income (loss)	(81,814)	(30,701)	(51,788)	(25,073)
Net income (loss) before income tax expense	(113,259)	(64,293)	(126,019)	(118,002)
Income tax expense (benefit)	(1,248)	547	641	(762)
Net income (loss)	(112,011)	(64,840)	(126,660)	(117,240)
Net income (loss) attributable to non-controlling interests	(57,783)	(41,602)	(67,759)	(98,559)
Net income (loss) attributable to Class A common stockholders	$ (54,228)	$ (23,238)	$ (58,901)	$ (18,681)
Net income (loss) per share attributable to Class A common stockholders, basic (in dollars per share)	$ (0.23)	$ (0.14)	$ (0.28)	$ (0.11)
Net income (loss) per share attributable to Class A common stockholders, diluted (in dollars per share)	$ (0.23)	$ (0.14)	$ (0.28)	$ (0.16)
Weighted-average shares outstanding:
Basic (in shares)	232,314,170	170,871,429	211,408,974	168,100,210
Diluted (in shares)	232,314,170	477,255,983	211,408,974	169,312,258
Capitated revenue
Revenue:
Total revenue	$ 625,895	$ 473,763	$ 1,955,739	$ 1,064,604
Fee-for-service and other revenue
Revenue:
Total revenue	$ 39,133	$ 25,168	$ 102,804	$ 52,510